Enter your search term above.

News

According to preliminary findings from a small study presented Monday at the Society of Thoracic Surgeons’ annual meeting, a new drug ‘lights up’ stray lung cancer cells when looked through an imaging technique, reducing cancer recurrence post-surgery. In fact, the study found that the new combination—dubbed intraoperative molecular imaging (IMI)—helped improve outcomes in surgeries of 1 out of 4 patients.

Though not involved in the study, LCRF Board Chair Brendon M. Stiles, MD, recently shared his thoughts on the study with HealthDay. He told the media outlet that the potential for the new technology is “exciting” for certain types of early lung cancer lesions that aren’t easy to see or feel. “There really shouldn’t be any side effects; it’s fast and user-friendly,” said Dr. Stiles. But he added that the technology may be somewhat limited because near infrared light doesn’t see deeply into the body.” Pre-op imaging has gotten so amazingly good, we’re finding earlier and earlier cancers. It’s hard to think they’d find nodules that weren’t on the CT scan.” 

Click here to read the full article and learn more about the study.

Catherine (center front) with some of the Clinical Trial Blazers team

Hundreds of participants—lung cancer patients, survivors, and advocates, young and old— took part in the 2019 New York Free to Breathe Walk last October. On event day, dozens of walkers were greeted with a hug from the same woman, Catherine Paykin, LCSW-R. Catherine, a social worker at NYU Perlmutter Cancer Center, was the common link between so many of the smiling faces at this year’s walk. She was team captain for NYU’s 2019 team, NYU Perlmutter Cancer Center Clinical Trial Blazers, recruiting a team of a whopping 175+ members over the course of just a few short months!

Catherine, like so many Free to Breathe team captains, is a go-getter. In a short amount of time, she raised over $50,000, 10 times her original fundraising goal!! And do you know what’s even more amazing? This was her first time as a team captain!

A group of Clinical Trial Blazers on walk day

So how did Catherine do it? In addition to inviting her patients, she recruited Audrey Sheridan, LCSW from the Brooklyn Perlmutter Cancer Center to rally forces in Kings County. Together they enlisted the help of eight NYU Perlmutter Cancer Center doctors, who in turn invited their patients to walk with them. And Catherine didn’t stop once people joined the team! She continually encouraged team members to set up their own personal fundraising goals and reach out to their family and friends for donations. She also provided updates to her team members on the top fundraisers and offered tips to help the team hit their next fundraising target.

Becoming a top fundraiser is much more doable than it might seem. Just keep Catherine’s words in mind: “Walking and raising money for research was a concrete way of letting my patients and families know that they are not alone. Our team of scientists, researchers, healthcare providers who joined the patients and families to walk across the Brooklyn Bridge gave all hope and encouragement.”

New York, NY (January 22, 2019) – The Lung Cancer Research Foundation® (LCRF), the largest lung cancer focused foundation in the US supporting lung cancer research, has unveiled its newly revamped website, lcrf.org.  The recently updated website has a fresh visual design, offers easy navigation and is mobile optimized.

LCRF is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. To date, LCRF has funded 370 research grants totaling nearly $34 million, the highest amount provided by an organization dedicated to funding lung cancer research.

The organization’s website rebuild was spearheaded by Speak Creative, a Tennessee-based digital agency. The site unifies LCRF’s quality content with the viewer, the lung cancer community, in mind. The homepage of the site contains three specific journeys— lung cancer patient/caregiver, lung cancer researcher and supporter/advocate—to help visitors navigate and easily obtain the information they are looking for.

“We are so proud and excited to debut our redesigned website,” said Dennis P. Chillemi, Executive Director, LCRF. “We hope that the new design will make for a more enjoyable user experience. Our goal is to make sure that visitors can easily find the information they are looking for, whether it’s information on the current research we are funding, the latest FDA approvals, or registration for an upcoming lung cancer community event.”

LCRF’s website will be updated regularly with new content including the latest lung cancer treatment advances, upcoming events and educational workshops, and updates on LCRF’s Scientific Grant Program and LCRF-funded investigators. Viewers can visit the new site and explore LCRF’s content by visiting www.lcrf.org.

# # #

About the Lung Cancer Research Foundation
The Lung Cancer Research Foundation® (LCRF) is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. LCRF’s mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer. To date, LCRF has funded 370 research grants, totaling nearly $34 million, the highest amount provided by a nonprofit organization dedicated to funding lung cancer research. In addition to funding lung cancer research, the organization offers awareness and educational programs and brings the lung cancer community together through Free to Breathe Walks and other events nationwide. For more information, visit lcrf.org.

LCRF is proud to support cutting-edge research that’s making a difference in how lung cancer will be treated. Work on small cell lung cancer by 2017 LCRF grantee, Dr. Hua Zhang, MD, PhD, was featured as the cover story in the January 2020 issue of Cancer Cell journal. 

The cover illustration concept came from Dr. Zhang along with co-authors Kristen Labbe and Dr. Catríona Dowling. In the illustration, small cell lung cancer (SCLC), an often aggressive and difficult to treat disease, is depicted as a colorful piñata. The baseball bat represents a newly developed compound that helps elicit an immune response in SCLC by disrupting the cell cycle and causing the release of cytokines, which are substances that can help activate the immune system. Depicted as candies, these substances attract immune T cells, which are depicted as children in the illustration. Showing that inhibiting a molecule known as CDK7 with this new compound leads to a more robust immune response, the investigators have paved the way for potentially improving the effectiveness of immunotherapies in SCLC. This important work will now be tested in the clinic, where it has the potential to prolong survival in SCLC.

A number of investigators and LCRF grantees contributed to this work, including Drs. Matthew Oser, MD, PhD; Kwok-Kin Wong, MD, PhD; Camilla Christensen, PhD; and Peter Hammerman, MD, PhD.

View the article here.

The New Year began with excellent news for the lung cancer community at large. A 2020 report by the American Cancer Society shows that we have experienced the largest ever single-year drop in cancer death rate between 2016-2017 when cancer deaths fell 2.2%. And even more good news: the sharpest decline in cancer deaths was seen in lung cancer and is mainly attributed to reduced smoking rates and advances in lung cancer treatment.

“The amazing work being done by lung cancer researchers and experts in the field is reaching the lung cancer community,” said Dennis Chillemi, Executive Director of LCRF. “More and more treatment options are becoming widely available for those living with lung cancer today, and this is a trend that we expect to continue.” In 2018 alone, we saw 10 FDA drug approvals for lung cancer treatments. “These new and encouraging statistics, highlight that our continued investment in biomedical research is working.”

Supporting research is the key to continuing this momentum. Together, we will help improve lung cancer outcomes.

To read the full study, click here. The American Cancer Society’s Cancer Facts & Figures can be found here.

Does one of your healthy habits for the new year include being active? If so, you can join Team LCRF and fundraise for lung cancer research while hitting your fitness goals! Any fitness activity can be turned into an endurance fundraiser. Running, swimming, biking, mountain climbing…you name it! Visit lcrf.org/get-started to learn more and jumpstart your goals today.

In addition, we have TWO special opportunities to join Team LCRF!

Apply now to run the 2020 TCS New York City Marathon (it’s the 50th anniversary!) with us on Sunday, November 1.

Is biking more your thing? Join Team LCRF in New York for the TD Five Boro Bike Tour, the country’s biggest bike ride, on Sunday, May 3.

Act fast! We have a limited number of spots available for each race. Apply by February 14. If you have questions, contact Alana Seger at aseger@lcrf.org.

PORT WASHINGTON, NY – The 12th Annual Tom Zangas Memorial Lung Cancer Foundation/Archangel Michael 5K Run/1K Walk on Saturday, Oct. 26 pushed the foundation past a significant milestone. On a brisk, sunny fall day with flags fluttering in the wind, 150 runners and walkers participated at North Hempstead Beach Park helping to raise an additional $60,000 for lung cancer research bringing the total raised by the foundation since its inception to more than $500,000.

The foundation provides grants to the Lung Cancer Research Foundation (LCRF) and the Perlmutter Cancer Center at NYU Langone to fund important research and community outreach.

Race winner was Thomas Theofilators in a time of 20:55. Second was Erica Kinloch of Manhasset just behind in 20:57. This was the closest finish in race history and the highest finish for a woman.

Leonard Zangas, father of Tom Zangas, who started the foundation with his wife Penelope, thanked the crowd prior to the race for the continued support of the community and generosity of contributors. “Half a million dollars is a significant contribution to fight this horrendous disease and support research and outreach to underserved communities,” he said. “It is a milestone that all of us should be proud of.”

Sam Rogers of LCRF thanked the Zangases and the Tom Zangas Memorial Lung Cancer Foundation for their contributions over the years, noting how important the funding has been in supporting important research that is saving lives. He described the great strides in treatment since Tom Zangas become ill more than a decade ago.

Grants to LCRF and NYU Langone have funded a variety of research projects including prevention and screening for early detection; identification of new biomarkers and the development of targeted therapies; and development of next-generation chemotherapeutic agents. Many of these projects have led to new avenues of research and important discoveries and helped usher in the era of personalized medicine in lung cancer treatment.

March 2019 | by Cristina Chin

Woman with a Child
Victoria with her son

We often measure our progress against personal milestones, an orientation of where we have been and where we are destined to go. Victoria Vargas remembered some of her unique milestones as she shared her story with LCRF.

One milestone: Victoria at the ripe young age of 13, breathless after walking up a flight of stairs. “I thought I was so out of breath because I needed more exercise,” Victoria explained. In reality, Victoria’s lung had collapsed and would collapse twice more in her life.

Another milestone: Right before her 23rd birthday, Victoria received a diagnosis of stage III spindle-cell sarcoma of the lung, a rare and aggressive disease that occurs in just 0.3-1.3% of all lung malignancies. “To me, it didn’t matter what story the statistics were saying about this disease,” she shared. In that moment, all Victoria could think about was her 5-year old son and how she was going to explain to him what she was going through. “I decided right then and there that I would tell him that Mom is going to be a survivor.”

After undergoing surgery to remove most of her right lung followed by months of chemotherapy and radiation treatment, Victoria received the good news that she was cancer free.

That was a milestone she could celebrate.

Victoria emphasized how supportive and encouraging her oncologist was throughout her treatment. She looks back fondly on the wealth of support she received from her healthcare team, family and friends.

As she had declared she would do, Victoria was able to tell her son that his mom is a survivor. While Victoria doesn’t define her life by her diagnosis, she is grateful every year when she remembers her lung cancer milestones because they are all a reminder that she is full of life and full of hope.

Victoria sought an outlet for sharing her story with others who need the reminder that the lung cancer journey can be a hopeful one. She discovered a flyer for the Lung Cancer Research Foundation’s walk to support lung cancer research at her treatment center.

Victoria has since been vocal about her journey, and first shared her story at LCRF’s 2018 Philadelphia Free to Breathe Walk. “Through my treatments, I began to realize how bright a future is becoming possible for people with this disease,” she observed. “New discoveries keep happening thanks to the amazing research being conducted.”

“If I could share one thing with you, it would be how thankful I am that there are people like you who are willing to listen and share your journey,” Victoria said. “Together we can cultivate each other’s milestones of hope. Best of all, there are so many ways to get involved in supporting lung cancer research within the LCRF community.”

Join Victoria and others in our community – visit lcrf.org/support-us to find out ways to get involved.

June 2017 | As told by Ruthie

My story started in April 2013 with a very bad cough. I was reluctant to see a doctor because that was my only symptom. The cough persisted long enough for my husband Marty to convince me to make an appointment with our primary care physician.

The doctor gave me a prescription for cough medicine with codeine and sent me for a chest X-ray, which showed I had pneumonia. He told me to continue taking the cough medicine, get plenty of rest, and come back for a follow-up visit in a week.

At the follow-up, I had no change in my condition. Three weeks later, I had another chest X-ray that also showed no change. Yet another chest X-ray three weeks after that had the same result, so the radiologist recommended a CT scan. The scan results were not good, and my doctor recommended that I see a thoracic surgeon for a biopsy.

Now I was getting scared. We interviewed three surgeons and chose the one my doctor had recommended. My whole family and a few close friends gathered in the waiting room on May 26, a date I will always remember. The news was not what we hoped to hear: I had stage IV metastatic non small cell adenocarcinoma. That day ended with many tears, much fear and unhappiness. I was in shock – I was not supposed to have something like this happen to me.

Decision time

Next came the research and a series of decisions. Where did I want to be treated, and by which doctor? Our first stop was the same hospital where I had my biopsy. We met with a thoracic oncologist whom my primary care physician had recommended. Her first words to me were, “Do you always get dressed up to go to the doctor? ” I thought that was rather rude, but even more harsh was hearing her prognosis that I had six months to two years to live. I didn’t like her much, and we never saw her again.

Second stop was at Hackensack, where we met with a doctor who was treating someone we knew for lung cancer. The facility was brand new, and the doctor was a very kind and compassionate man – informative and caring. I liked him very much. Before we left the hospital, I asked if I could see the chemo suite. They led me to a large open room filled with lounge chairs where people were sitting around with IVs in their arms. I left there in tears. I could not see myself sitting in that room without any privacy.

They say the third time is a charm, and in our case, it was. Our next appointment was with Dr. Mark Kris at Memorial Sloan Kettering. After meeting him, talking to him, and being examined by him, I was feeling hopeful for the first time since my diagnosis. I knew this was the place I wanted to receive my treatments and he was the doctor I wanted to treat me. He intended to use the same two drugs for my chemo as the other two doctors but he was adding a third one to the mix. I chose him not for his treatment plan, but because I liked his demeanor, confidence and his way of putting things. He said it was his intention to take a horrible diagnosis and turn it into a chronic illness. Then he said he measured success in years. I knew I could trust him, literally, with my life.

The other person who saved my life in a different sense was and continues to be my amazing husband. I could never have made this journey without him by my side. Marty has been there every step of the way, for every doctor appointment, every treatment and even every phone call. He is caring, supportive, intelligent and patient, and I can’t imagine a better advocate in the world. He can deal with insurance companies without losing his temper, which is not an easy thing to do. Sometimes he refers to their paperwork policies as “formal abuse.” Every time I have a scan, he has to debate them. For instance, their doctor – someone I’ve never seen – thinks I should have a scan with contrast, while my own oncologist disagrees. Marty stands up for me, stays positive, loving and caring, and helps me in any way he can.

No mistake – this is a challenging journey. First it was the shock of hearing the diagnosis, the dreaded word “cancer.” Next came dealing with the first question everyone with lung cancer is asked: “Did you smoke?” The suggestion that it’s your fault for getting this disease really hurts. The early morning wake-ups to get to New York for eight-hour treatments were definitely unpleasant, as were the following three days after each session curled up in a ball binge-watching some TV series we had never seen. Also alarming were the times I woke up to blood on my pillow and didn’t know where it came from. I got used to the nosebleeds and bleeding gums, but when I started bleeding from my eye I was concerned. And of course, both the disease and treatment can make you fatigued.

My initial treatment included three drugs in the infusion: cisplatin, bevacizumab and pemetrexed. Dr. Kris was hoping for six treatments with the cisplatin, but we only got to four because it started having a negative effect on my kidneys. I was nervous about giving up a drug that was working so well. From July 2013 – April 2014, my tumors continued to shrink. My last treatment was May 3, 2016 – my blood pressure was getting too high. While I have gone a year without treatment, my latest scan showed no sign of active disease.

Big changes, and my dream team

After my diagnosis, I made a lot of changes in my life and eliminated as much negativity as I could. I even saw that cancer offered me a gift – I learned how to live in the present moment. I read Bernie Siegel’s books, and his writings gave me the courage to ask Dr. Kris for a hug. I later had the opportunity to meet Dr. Siegel and share my experience with him. I began reading affirmations every morning and subscribed to a daily messages including Lessons Learned in Life and Ralph Marston’s The Daily Motivator.

My children have been by my side for every decision-making appointment. My friends and acquaintances are supportive with their prayers and positive thoughts. When they tell me what an inspiration I am, I feel my inner strength growing.

I met one of my friends after I discovered yoga: my amazing teacher, Heather Bivona. Heather is a ray of sunshine who teaches me at my home 4 or 5 times a week. She has been incredibly supportive, believes in me, and always sees the positive in all situations. We focus on my breathing and any other area that needs attention. Heather is definitely a member of my dream team of supporters.

Also on my dream team is Amy Arvary, a hypnotherapist and one of the most positive people I have ever met. Amy helped me learn to relax and meditate, to focus on what I wanted, and to manifest my healthy self. She taped our sessions so I can listen to them whenever I need to hear her voice guiding me through the chaos or scary voices in my head. She is loving, supportive and fun. Having her in my life helps me believe in myself and gives me the courage to fight even when I am exhausted.

Last, but definitely not least, is my dearest friend Marcia. We have been friends since high school, attended each other’s weddings and try to see each other whenever we can. She has been there for me every step of the way, with daily phone calls and near-weekly lunches. She always talks me through scan anxiety – my nerves pre-scan and then my fear waiting for the results. On the days I was curled up in a ball on the couch, she would spend hours on the phone with me. I know if I ever needed anything, she would be here in the drop of a hat. We live about an hour apart and we used to take turns driving to see each other to meet for lunch. While I was undergoing treatment, she was always there. If I could pick my sister it would be her. She is my forever friend.

My friends and family have supported me in the Northern New Jersey Free to Breathe (now merged with the Lung Cancer Research Foundation) event at Horseshoe Lake in Succasunna, NJ. Heather, my yoga teacher, has walked by my side as part of my team. She listened to my breathing as we walked, talking me though the times I felt short of breath. She encouraged me so I could finish ahead of my team and thank them at the finish line.

Our team came in 2nd place for fundraising the first year. One of my granddaughters was so touched by the event that she decided to raise money for this wonderful organization as her “Mitzvah” project for her Bat Mitzvah in September 2016. In our second year, we were the top fundraising team.

In 2017, we were asked to be the honorary chairs for the event. We are determined to double the money we raised last year and are going to try soliciting local businesses and large pharmaceutical companies. I became involved because I want to raise as many funds as I can for lung cancer research. The many advances in lung cancer treatment has helped me remain hopeful. People are living longer with this disease, and yes – I am hoping they find a cure in my lifetime. If I don’t see a cure, then I’m glad I can help work toward a future cure for others.

October 2017 | As told by Marie

It’s just about 7 years ago that quite by accident, a suspicious nodule was discovered in my right lung. The spot was revealed during a CT scan after I went to the ER for abdominal pain, thinking I might have appendicitis. To my shock and horror, I found out that I had lung cancer. I had no symptoms of any kind, no family history, and I had never smoked a day in my life.

I couldn’t believe this was happening to me. After a successful lobectomy with no need for further treatment, I truly felt I had dodged a bullet. I was so relieved, especially when every follow-up scan was clear.

My relief ended suddenly in March 2015. After experiencing months of debilitating thigh, leg and back pain, for which I was receiving chiropractic treatment to no avail, I finally went to an orthopedist. There I learned that the cancer had metastasized to my bones. I had been walking around with a pelvic fracture, and further scans showed spots in my ribs, lung and brain as well.

My very core was shaken, and life would NEVER be the same. In the darkest and scariest time of my life, while I was having biopsies and wondering what would become of me, I was given some amazing news. I had the EGFR receptor mutation, and a drug named Tarceva had been found to block or slow the EGFR signals. This newer treatment – which wasn’t even available a few years ago – can slow the growth and even kill off cancer cells. By the grace of God and medical research, I am able to live with lung cancer as a chronic disease and not an automatic death sentence!

Marie shared how research helped write her story in a fall 2018 video, shown below.

My Tarceva treatment began in April 2015, two days before my beautiful grandson Anthony was born. At that time, I didn’t know whether I would be around to watch him and my other grandchildren grow. I was devastated to think that Anthony, Isabella (then 2 years old) and Benjamin (who was 1) might not have the opportunity to know and remember me – the Grandma who loves them with all her heart. Thankfully, and yes, also by the grace of God, this treatment is giving me many more years with my family. I am enjoying all the milestones in life that I have looked forward to experiencing. I’ve enjoyed family vacations and wonderful times spent together with family and friends, bucket list trips to Italy and the Grand Canyon, holidays, birthday celebrations, kiddie parties, first days of pre-school, dance recitals and lots of babysitting! My husband and I recently turned 60, and our amazing children surprised us with a party. We enjoyed family and friends, and held our grandchildren. We laughed and made more wonderful lifelong memories. Life is good!

When I spotted a Northern New Jersey Free to Breathe Walk flyer at Morristown Medical Center, my home away from home, I had to take a closer look. I saw that the walk would be taking place in October, and I just knew I had to be a part of it. I was delighted to join all the amazing people – fellow warriors, survivors, supporters, friends and family – at this awesome fundraising event! After all, the research funded by generous participants at events like the Northern New Jersey Walk has given me precious years with the people I love. As a lung cancer survivor, I told my story from the stage on event day and am sharing it with you now.

Because of my newfound perspective and cancer journey, I never take a minute of my life for granted, I embrace and enjoy every day that is given me, and I am grateful. I look forward to a long life.

I am so thankful to all of you who support lung cancer research by giving your time and resources to help put an end to this awful disease.